- Home
- JOB vs INAB Comparison
JOB vs INAB Comparison
Compare JOB & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JOB | INAB |
|---|---|---|
| Founded | 1893 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 22.9M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | JOB | INAB |
|---|---|---|
| Price | $0.23 | $1.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $180.00 |
| AVG Volume (30 Days) | ★ 175.3K | 36.2K |
| Earning Date | 06-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $96,504,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.17 | $0.12 |
| 52 Week High | $0.27 | $4.20 |
Technical Indicators
Market Signals| Indicator | JOB | INAB |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 42.29 |
| Support Level | $0.19 | $1.52 |
| Resistance Level | $0.24 | $2.55 |
| Average True Range (ATR) | 0.02 | 0.14 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 47.61 | 37.02 |
Price Performance
Historical ComparisonAbout JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.